Sam Susan, Vellanki Priyathama, Yalamanchi Sudha K, Bergman Richard N, Dunaif Andrea
Section of Adult and Pediatric Endocrinology, Diabetes, & Metabolism, University of Chicago, Chicago, IL, United States.
Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Metabolism. 2017 Jun;71:125-131. doi: 10.1016/j.metabol.2017.03.008. Epub 2017 Mar 22.
Premenopausal women have blunted counter-regulatory hormone responses (CRR) to hypoglycemia compared to men. Postmenopausal women have CRR similar to men; the premenopausal pattern can be restored by estrogen. However, glucagon and pancreatic polypeptide (PP) responses remain lower in postmenopausal women than in men. Since hyperandrogenemia contributes to the metabolic phenotype of polycystic ovary syndrome (PCOS), we hypothesize that CRR to hypoglycemia especially of glucagon and PP is exaggerated in premenopausal women with PCOS compared to premenopausal control women.
Ten obese women with PCOS and 9 control women of similar ethnicity, age and BMI underwent determination of CRR in response to hypoglycemia during 180-min 60mU/m/min insulin dose hypoglycemic clamp with isotopic assessment of endogenous glucose production (EGP). To assess CRR to hypoglycemia, glucagon, cortisol, growth hormone (GH), epinephrine, norepinephrine, PP, lactate, free fatty acid (FFA), β-hydroxybutyrate, and glycerol levels were sampled at 15-min intervals throughout the clamp.
Incremental glucagon levels were ~3-fold higher during hypoglycemia (P=0.03) in PCOS. Postabsorptive, steady-state and incremental GH, cortisol, epinephrine, norepinephrine, PP, FFA, glycerol and β-hydroxybutyrate did not differ. At target glucose levels of ~52mg/dL, insulin mediated glucose disposal (IMGD) was decreased by ~40% (P=0.02) in PCOS, compared to control women, despite ~20% higher steady-state insulin levels (P=0.03). Neither postabsorptive nor steady-state EGP differed. However, postabsorptive lactate levels were ~50% higher (P=0.02). PCOS status (P=0.04) and IMGD (P=0.02) predicted the differential glucagon response to hypoglycemia in separate regression models, however, neither parameter remained an independent predictor in a combined model.
Glucagon responses were increased in PCOS, whereas other CRR did not differ. Women with PCOS were insulin resistant under hypoglycemic conditions and higher postabsorptive lactate levels in PCOS were consistent with this finding. Insulin resistance may have contributed to exaggerated glucagon response to hypoglycemia in PCOS.
与男性相比,绝经前女性对低血糖的反调节激素反应(CRR)减弱。绝经后女性的CRR与男性相似;绝经前的模式可通过雌激素恢复。然而,绝经后女性的胰高血糖素和胰多肽(PP)反应仍低于男性。由于高雄激素血症导致多囊卵巢综合征(PCOS)的代谢表型,我们假设与绝经前对照女性相比,PCOS绝经前女性对低血糖的CRR,尤其是胰高血糖素和PP的反应会增强。
10名患有PCOS的肥胖女性和9名种族、年龄和体重指数(BMI)相似的对照女性,在180分钟内以60mU/m/分钟的胰岛素剂量进行低血糖钳夹,并通过同位素评估内源性葡萄糖生成(EGP),以测定对低血糖的CRR。为评估对低血糖的CRR,在整个钳夹过程中每隔15分钟采集一次胰高血糖素、皮质醇、生长激素(GH)、肾上腺素、去甲肾上腺素、PP、乳酸、游离脂肪酸(FFA)、β-羟基丁酸和甘油水平的样本。
在低血糖期间,PCOS患者的胰高血糖素增量水平高出约3倍(P=0.03)。吸收后、稳态及增量的GH、皮质醇、肾上腺素、去甲肾上腺素、PP、FFA、甘油和β-羟基丁酸无差异。在目标血糖水平约为52mg/dL时,尽管稳态胰岛素水平高出约20%(P=0.03),但与对照女性相比,PCOS患者的胰岛素介导的葡萄糖处置(IMGD)降低了约40%(P=0.02)。吸收后和稳态的EGP均无差异。然而,吸收后的乳酸水平高出约50%(P=0.02)。在单独的回归模型中,PCOS状态(P=0.04)和IMGD(P=0.02)可预测对低血糖的胰高血糖素差异反应,但在联合模型中,这两个参数均不再是独立预测因子。
PCOS患者的胰高血糖素反应增强,而其他CRR无差异。PCOS女性在低血糖条件下存在胰岛素抵抗,PCOS患者吸收后较高的乳酸水平与此发现一致。胰岛素抵抗可能导致PCOS患者对低血糖的胰高血糖素反应增强。